ARWR
Arrowhead Pharmaceuticals Inc
NASDAQ: ARWR · HEALTHCARE · BIOTECHNOLOGY
$70.53
+0.57% today
Updated 2026-04-29
Market cap
$9.88B
P/E ratio
44.08
P/S ratio
9.05x
EPS (TTM)
$1.60
Dividend yield
—
52W range
$12 – $77
Volume
2.2M
Arrowhead Pharmaceuticals Inc (ARWR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$70.53
12-Month target
$48.05
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.2B | $0.2B | $0.0B | $0.8B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 18.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.